User profiles for Jennifer. A. Juno
 | Jennifer A JunoUniversity of Melbourne Verified email at unimelb.edu.au Cited by 8999 |
[HTML][HTML] Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
central to long-term control of the current pandemic. Despite our rapidly advancing knowledge …
central to long-term control of the current pandemic. Despite our rapidly advancing knowledge …
[HTML][HTML] Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement. …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement. …
[HTML][HTML] Invariant NKT cells: regulation and function during viral infection
Natural killer T cells (NKT cells) represent a subset of T lymphocytes that express natural
killer (NK) cell surface markers. A subset of NKT cells, termed invariant NKT cells (iNKT), …
killer (NK) cell surface markers. A subset of NKT cells, termed invariant NKT cells (iNKT), …
[HTML][HTML] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …
correlates of protection to assist in the future deployment of vaccines. To address this, we …
[HTML][HTML] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
[HTML][HTML] Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Background Several SARS-CoV-2 variants of concern have been identified that partly escape
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
[HTML][HTML] Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
[HTML][HTML] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine
Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
…, CE van de Sandt, JA Juno… - Proceedings of the …, 2020 - National Acad Sciences
An improved understanding of human T cell-mediated immunity in COVID-19 is important
for optimizing therapeutic and vaccine strategies. Experience with influenza shows that …
for optimizing therapeutic and vaccine strategies. Experience with influenza shows that …